| • |
Synthesis, characterization, cytotoxicity evaluation and molecular docking study of new bis-chalcone, fused-pyrimidine and fused-pyrazoline derivatives. |
2023 |
| • |
Synthesis, anticancer activity and docking studies of pyrazoline and pyrimidine derivatives as potential epidermal growth factor receptor (EGFR) inhibitors. |
2022 |
| • |
. Synthesis, Characterization, Molecular Docking and Cytotoxicity Evaluation of New Thienyl Chalcone Derivatives against Breast Cancer Cells |
2022 |
| • |
Molecular Docking Study, Synthesis and Characterization of New Hybrid Anthracene-Thiophene Compounds with Chalcone and Pyridine Scaffolds |
2022 |
| • |
Synthesis, Characterization and Molecular Docking of New Naphthalene-Based Chalcone and Pyrazoline Compounds. |
2022 |
| • |
Synthesis, Characterization, Cytotoxicity Study and Docking Studies of New Fusedpyrazoline Derivatives derived from Bis-Chalcones Against Breast Cancer cells |
2021 |
| • |
Synthesis, characterization, docking study and biological evaluation of new chalcone, pyrazoline, and pyrimidine derivatives as potent antimalarial compounds |
2021 |
| • |
Docking studies, synthesis, characterization, and cytotoxicity activity of new bis-chalcones derivatives |
2021 |
| • |
EGFR Inhibitors and Apoptosis Inducers: Design, Docking, Synthesis, and Anticancer Activity of Novel Tri- Chalcone Derivatives |
2021 |
| • |
Design, synthesis, characterization, and cytotoxicity activity evaluation of mono-chalcones and new pyrazolines derivatives. |
2020 |
| • |
SYNTHESIS, CHARACTERISATION OF SOME NEW SCHIFF BASE FOR THE PIPERIDINIUM 4-AMINO-5-SUBSTITUTED-4H-1, 2, 4-TRIAZOLE3-THIOLATE, AND THEIR IN-VITRO ANTICANCER ACTIVITIES |
2020 |
